FBC
SAGE

Fairfield, Bush & Co’s Sage Therapeutics SAGE Stock Holding History

Fairfield, Bush & Co’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,000
Closed -$235K – 420
2023
Q2 		$235K Hold
5,000
– – 0.06% 139
2023
Q1 		$210K Buy
+5,000
New +$215K 0.07% 137
2021
Q4 		– Sell
-5,000
Closed -$222K – 158
2021
Q3 		$222K Buy
+5,000
New +$229K 0.07% 152
2021
Q2 		– Sell
-5,000
Closed -$374K – 161
2021
Q1 		$374K Hold
5,000
– – 0.11% 129
2020
Q4 		$433K Hold
5,000
– – 0.13% 111
2020
Q3 		$306K Hold
5,000
– – 0.1% 118
2020
Q2 		$208K Buy
+5,000
New +$181K 0.07% 132

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return